Tuberculosis elimination: where are we now?

Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) and partners to improve its control. In 2014 WHO launched a new global strategy (End TB) with a vision of a world free of TB, and a 2035 goal o...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:European respiratory review Ročník 27; číslo 148; s. 180035
Hlavní autori: Matteelli, Alberto, Rendon, Adrian, Tiberi, Simon, Al-Abri, Seif, Voniatis, Constantia, Carvalho, Anna Cristina C., Centis, Rosella, D'Ambrosio, Lia, Visca, Dina, Spanevello, Antonio, Battista Migliori, Giovanni
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England European Respiratory Society 30.06.2018
Predmet:
Health and Politics
ISSN:0905-9180, 1600-0617, 1600-0617
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) and partners to improve its control. In 2014 WHO launched a new global strategy (End TB) with a vision of a world free of TB, and a 2035 goal of TB elimination (defined as less than one incident case per million). The aim of this article is to summarise the theoretical bases of the End TB Strategy and to analyse progresses and persistent obstacles on the way to TB elimination. The evolution of the WHO recommended strategies of TB control (Directly Observed Therapy, Short Course (DOTS), Stop TB and End TB) are described and the concept of TB elimination is discussed. Furthermore, the eight core activities recently proposed by WHO as the milestones to achieve TB elimination are discussed in detail. Finally, the recently published experiences of Cyprus and Oman on their way towards TB elimination are described, together with the regional experience of Latin America. New prevention, diagnostic and treatment tools are also necessary to increase the speed of the present TB incidence decline.
AbstractList Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) and partners to improve its control. In 2014 WHO launched a new global strategy (End TB) with a vision of a world free of TB, and a 2035 goal of TB elimination (defined as less than one incident case per million). The aim of this article is to summarise the theoretical bases of the End TB Strategy and to analyse progresses and persistent obstacles on the way to TB elimination. The evolution of the WHO recommended strategies of TB control (Directly Observed Therapy, Short Course (DOTS), Stop TB and End TB) are described and the concept of TB elimination is discussed. Furthermore, the eight core activities recently proposed by WHO as the milestones to achieve TB elimination are discussed in detail. Finally, the recently published experiences of Cyprus and Oman on their way towards TB elimination are described, together with the regional experience of Latin America. New prevention, diagnostic and treatment tools are also necessary to increase the speed of the present TB incidence decline.
Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) and partners to improve its control. In 2014 WHO launched a new global strategy (End TB) with a vision of a world free of TB, and a 2035 goal of TB elimination (defined as less than one incident case per million). The aim of this article is to summarise the theoretical bases of the End TB Strategy and to analyse progresses and persistent obstacles on the way to TB elimination. The evolution of the WHO recommended strategies of TB control (Directly Observed Therapy, Short Course (DOTS), Stop TB and End TB) are described and the concept of TB elimination is discussed. Furthermore, the eight core activities recently proposed by WHO as the milestones to achieve TB elimination are discussed in detail. Finally, the recently published experiences of Cyprus and Oman on their way towards TB elimination are described, together with the regional experience of Latin America. New prevention, diagnostic and treatment tools are also necessary to increase the speed of the present TB incidence decline.
Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) and partners to improve its control. In 2014 WHO launched a new global strategy (End TB) with a vision of a world free of TB, and a 2035 goal of TB elimination (defined as less than one incident case per million). The aim of this article is to summarise the theoretical bases of the End TB Strategy and to analyse progresses and persistent obstacles on the way to TB elimination.The evolution of the WHO recommended strategies of TB control (Directly Observed Therapy, Short Course (DOTS), Stop TB and End TB) are described and the concept of TB elimination is discussed. Furthermore, the eight core activities recently proposed by WHO as the milestones to achieve TB elimination are discussed in detail. Finally, the recently published experiences of Cyprus and Oman on their way towards TB elimination are described, together with the regional experience of Latin America.New prevention, diagnostic and treatment tools are also necessary to increase the speed of the present TB incidence decline.Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) and partners to improve its control. In 2014 WHO launched a new global strategy (End TB) with a vision of a world free of TB, and a 2035 goal of TB elimination (defined as less than one incident case per million). The aim of this article is to summarise the theoretical bases of the End TB Strategy and to analyse progresses and persistent obstacles on the way to TB elimination.The evolution of the WHO recommended strategies of TB control (Directly Observed Therapy, Short Course (DOTS), Stop TB and End TB) are described and the concept of TB elimination is discussed. Furthermore, the eight core activities recently proposed by WHO as the milestones to achieve TB elimination are discussed in detail. Finally, the recently published experiences of Cyprus and Oman on their way towards TB elimination are described, together with the regional experience of Latin America.New prevention, diagnostic and treatment tools are also necessary to increase the speed of the present TB incidence decline.
Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) and partners to improve its control. In 2014 WHO launched a new global strategy (End TB) with a vision of a world free of TB, and a 2035 goal of TB elimination (defined as less than one incident case per million). The aim of this article is to summarise the theoretical bases of the End TB Strategy and to analyse progresses and persistent obstacles on the way to TB elimination. The evolution of the WHO recommended strategies of TB control (Directly Observed Therapy, Short Course (DOTS), Stop TB and End TB) are described and the concept of TB elimination is discussed. Furthermore, the eight core activities recently proposed by WHO as the milestones to achieve TB elimination are discussed in detail. Finally, the recently published experiences of Cyprus and Oman on their way towards TB elimination are described, together with the regional experience of Latin America. New prevention, diagnostic and treatment tools are also necessary to increase the speed of the present TB incidence decline. The theoretical principles and the available examples of countries moving towards TB elimination are described in this article http://ow.ly/q8wN30k9UOW
Author Rendon, Adrian
Visca, Dina
Spanevello, Antonio
Tiberi, Simon
Carvalho, Anna Cristina C.
Centis, Rosella
D'Ambrosio, Lia
Al-Abri, Seif
Matteelli, Alberto
Voniatis, Constantia
Battista Migliori, Giovanni
AuthorAffiliation 1 University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV co-infection and for TB elimination, University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy
2 Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias, Hospital Universitario de Monterrey, Monterrey, México
10 Dept of Clinical and Experimental Medicine, University of Insubria, Varese, Italy
3 Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK
4 Ministry of Health, Muscat, Oman
9 Pneumology Dept, Maugeri Care and Research Institute, Tradate, Italy
6 Laboratory of Innovations in Therapies, Education and Bioproducts (LITEB), Oswaldo Cruz Institute (IOC), FioCruz, Rio de Janeiro, Brazil
7 World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy
8 Public Health Consulting Group, Lugano, Switzerland
5 Clinical Laboratories, Ministry of Health, Nicosi
AuthorAffiliation_xml – name: 10 Dept of Clinical and Experimental Medicine, University of Insubria, Varese, Italy
– name: 3 Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK
– name: 1 University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV co-infection and for TB elimination, University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy
– name: 5 Clinical Laboratories, Ministry of Health, Nicosia, Cyprus
– name: 6 Laboratory of Innovations in Therapies, Education and Bioproducts (LITEB), Oswaldo Cruz Institute (IOC), FioCruz, Rio de Janeiro, Brazil
– name: 9 Pneumology Dept, Maugeri Care and Research Institute, Tradate, Italy
– name: 2 Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias, Hospital Universitario de Monterrey, Monterrey, México
– name: 4 Ministry of Health, Muscat, Oman
– name: 7 World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy
– name: 8 Public Health Consulting Group, Lugano, Switzerland
Author_xml – sequence: 1
  givenname: Alberto
  surname: Matteelli
  fullname: Matteelli, Alberto
– sequence: 2
  givenname: Adrian
  surname: Rendon
  fullname: Rendon, Adrian
– sequence: 3
  givenname: Simon
  surname: Tiberi
  fullname: Tiberi, Simon
– sequence: 4
  givenname: Seif
  surname: Al-Abri
  fullname: Al-Abri, Seif
– sequence: 5
  givenname: Constantia
  surname: Voniatis
  fullname: Voniatis, Constantia
– sequence: 6
  givenname: Anna Cristina C.
  surname: Carvalho
  fullname: Carvalho, Anna Cristina C.
– sequence: 7
  givenname: Rosella
  orcidid: 0000-0002-8551-3598
  surname: Centis
  fullname: Centis, Rosella
– sequence: 8
  givenname: Lia
  orcidid: 0000-0002-7000-5777
  surname: D'Ambrosio
  fullname: D'Ambrosio, Lia
– sequence: 9
  givenname: Dina
  surname: Visca
  fullname: Visca, Dina
– sequence: 10
  givenname: Antonio
  surname: Spanevello
  fullname: Spanevello, Antonio
– sequence: 11
  givenname: Giovanni
  orcidid: 0000-0002-2597-574X
  surname: Battista Migliori
  fullname: Battista Migliori, Giovanni
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29898905$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9rGzEQxUVJaGynX6CH4mMgbDpaSSuph4RikjYQyCU5C1l_bIX1KpV2Y_rto7Xj0vRQhBA8vfkNM2-KjrrYOYQ-Y7jAWJCvuAGABvMLAMKqGrD4gCajWI3qEZqABFZJLOAETXN-AqDQAP-ITmopygE2QecPw9IlM7Qxhzx3bdiETvchdt_m27VLbq7L3bp5F7dXp-jY6za7T2_vDD3eXD8sflZ39z9uF9_vKsMI7atGSqq9t7y2hmsjaeM8lkvpMQZKhBC1ZNYSYomttWRNUblZMlNchHtsyAzd7rk26if1nMJGp98q6qB2QkwrpVMfTOsUEdY4WxAcM-opF54RL2RNDHEaNC-syz3reVhuXDF3fdLtO-j7ny6s1Sq-KEmFoKwpgLM3QIq_Bpd7tQnZuLbVnYtDVjWwMgLBJYMZ-vJ3rz9NDtsuBrE3mBRzTs4rE_rdtkvr0CoMagxWHYJVY7BqDLaU1v-UHuj_KXoFAcCjQw
CitedBy_id crossref_primary_10_1183_20734735_0079_2021
crossref_primary_10_1016_j_amjmed_2021_01_039
crossref_primary_10_1016_j_ijid_2025_107966
crossref_primary_10_1111_jam_14478
crossref_primary_10_1371_journal_pone_0277843
crossref_primary_10_3390_antibiotics10111355
crossref_primary_10_1183_23120541_00511_2021
crossref_primary_10_1016_j_jtemb_2020_126515
crossref_primary_10_1186_s13063_020_04324_z
crossref_primary_10_3390_tropicalmed7100288
crossref_primary_10_1016_j_idc_2019_09_002
crossref_primary_10_3390_genes10010053
crossref_primary_10_1038_s43856_022_00145_0
crossref_primary_10_1186_s12879_023_08197_w
crossref_primary_10_1136_bmjgh_2018_001135
crossref_primary_10_1590_0037_8682_0060_2022
crossref_primary_10_1097_MD_0000000000039052
crossref_primary_10_3389_fpubh_2019_00306
crossref_primary_10_7759_cureus_64904
crossref_primary_10_1186_s13756_021_00995_8
crossref_primary_10_1183_13993003_02396_2022
crossref_primary_10_3389_fphar_2022_891711
crossref_primary_10_1016_S1473_3099_24_00007_0
crossref_primary_10_3201_eid2603_190525
crossref_primary_10_1016_j_pulmoe_2021_07_003
crossref_primary_10_1183_13993003_02000_2024
crossref_primary_10_1186_s12879_023_08264_2
crossref_primary_10_1183_16000617_0106_2018
crossref_primary_10_1590_0034_7167_2023_0025pt
crossref_primary_10_1371_journal_pone_0247894
crossref_primary_10_3390_tropicalmed10060154
crossref_primary_10_1016_j_ijid_2020_02_042
crossref_primary_10_1016_j_tmaid_2020_101734
crossref_primary_10_20307_nps_2025_31_2_111
crossref_primary_10_1186_s12879_025_11068_1
crossref_primary_10_3390_tropicalmed9030054
crossref_primary_10_1016_j_bbagen_2023_130378
crossref_primary_10_1016_j_ijid_2022_02_047
crossref_primary_10_1016_j_ijtb_2023_09_001
crossref_primary_10_1073_pnas_2207022119
crossref_primary_10_1183_13993003_01578_2019
crossref_primary_10_1016_j_ijid_2020_09_034
crossref_primary_10_1080_07391102_2024_2335292
crossref_primary_10_1093_cid_ciz575
crossref_primary_10_3389_fmicb_2021_754352
crossref_primary_10_1177_22799036251336969
crossref_primary_10_1186_s13643_025_02888_y
crossref_primary_10_1016_j_compbiolchem_2020_107205
crossref_primary_10_1590_0034_7167_2023_0025
crossref_primary_10_3390_jcm9010101
crossref_primary_10_1016_j_ijtb_2022_06_005
crossref_primary_10_1016_j_ijid_2021_01_007
crossref_primary_10_1186_s12954_023_00855_1
crossref_primary_10_3390_ijerph16010028
crossref_primary_10_1136_bmjresp_2023_001894
crossref_primary_10_1183_13993003_00540_2022
crossref_primary_10_1016_j_lpm_2022_104112
crossref_primary_10_1038_s41429_021_00462_x
crossref_primary_10_3389_fmed_2022_927579
crossref_primary_10_3389_fmed_2021_709793
crossref_primary_10_3201_eid2703_203840
crossref_primary_10_3390_ijms26104522
crossref_primary_10_3390_pharmaceutics16070857
Cites_doi 10.1183/09031936.00079413
10.1016/j.ijid.2016.11.416
10.1183/09031936.00204611
10.1183/13993003.00214-2016
10.1183/13993003.01549-2016
10.1056/NEJMp1512139
10.1183/13993003.01992-2016
10.1056/NEJMc1212308
10.1183/13993003.00956-2016
10.1183/09031936.00134712
10.1093/cid/civ609
10.1183/13993003.00606-2015
10.1183/13993003.01245-2015
10.1183/09031936.02.00261402
10.1183/13993003.01278-2015
10.1016/S0140-6736(15)60570-0
10.1183/09031936.00022912
10.1183/09031936.00136312
10.1586/eri.12.168
10.1183/13993003.00274-2018
10.1183/13993003.00463-2017
10.1183/13993003.02445-2016
10.1183/13993003.00223-2017
10.1183/13993003.00753-2017
10.1016/S2214-109X(18)30189-X
10.1183/09031936.00019410
10.1183/13993003.00146-2017
10.1016/j.rppnen.2017.10.009
10.1183/09031936.00064314
10.1513/AnnalsATS.201608-592PS
10.1183/13993003.00061-2017
10.1016/j.arbres.2016.10.021
10.1016/j.rmed.2017.11.012
10.1016/S2214-109X(18)30195-5
10.1183/13993003.00840-2016
10.1183/13993003.02242-2016
10.1146/annurev-publhealth-031912-114431
10.1183/13993003.00098-2018
10.1183/13993003.00637-2016
10.1183/13993003.02309-2016
10.1183/09031936.00116011
10.1183/09031936.00135014
10.1183/13993003.02146-2015
10.3201/eid2310.170834
10.1183/13993003.02027-2017
10.1183/09031936.00198813
10.1183/13993003.00705-2016
10.1183/13993003.01459-2016
10.1183/13993003.00377-2016
10.1183/09031936.00191712
10.1183/13993003.00387-2017
10.1016/S0140-6736(15)00322-0
10.1183/13993003.01324-2015
10.1016/j.rppnen.2017.10.005
10.1183/09031936.00145014
10.1183/13993003.00228-2017
10.1183/09031936.00157212
10.1183/09031936.00009509
10.1183/13993003.01597-2015
10.1183/09031936.96.09051097
10.1183/09031936.00084310
10.1183/13993003.01249-2016
10.1016/j.ijid.2017.01.029
10.1093/jac/dkp265
10.1016/j.rppnen.2017.12.002
10.1183/09031936.00044314
10.1183/13993003.01891-2015
10.1183/09031936.00195210
10.1183/13993003.01462-2017
10.1183/13993003.02678-2017
10.1183/09031936.00053012
10.1183/09031936.00203811
10.1183/09031936.00025910
10.1016/j.rppnen.2017.11.003
10.1183/13993003.02308-2016
10.1183/13993003.02185-2015
10.1016/j.arbres.2017.07.004
10.1183/09031936.00216613
10.1183/09031936.00214014
10.1016/S1473-3099(16)00070-0
10.5588/ijtld.16.0940
10.1590/s1806-37562017000000449
10.1183/09031936.00132114
10.1183/13993003.01967-2016
10.1183/13993003.02267-2017
ContentType Journal Article
Copyright Copyright ©ERS 2018.
Copyright ©ERS 2018. 2018
Copyright_xml – notice: Copyright ©ERS 2018.
– notice: Copyright ©ERS 2018. 2018
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1183/16000617.0035-2018
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate TB elimination: where are we now?
EISSN 1600-0617
ExternalDocumentID oai_doaj_org_article_38dced6107154f478f53f8923c3ea0a7
PMC9488456
29898905
10_1183_16000617_0035_2018
Genre Journal Article
GroupedDBID ---
29G
2WC
5GY
5VS
6~0
6~1
AAYXX
ABOCM
ABSQV
ACEMG
ADBBV
ADMOG
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
BTFSW
CITATION
DIK
DU5
E3Z
EBS
EE-
EJD
F5P
F9R
GROUPED_DOAJ
GX1
H13
INIJC
KQ8
OK1
R0Z
RHI
RNS
RPM
TER
TR2
W8F
WOQ
AIPOO
M~E
NPM
RHF
7X8
5PM
ID FETCH-LOGICAL-c534t-6994affd72dc7ac946ef19b9f11043888295dd33d3d2a9561047cb5cef137f1c3
IEDL.DBID DOA
ISICitedReferencesCount 82
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000437470300019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0905-9180
1600-0617
IngestDate Fri Oct 03 12:42:12 EDT 2025
Tue Sep 30 17:17:58 EDT 2025
Thu Sep 04 19:26:26 EDT 2025
Wed Feb 19 02:42:59 EST 2025
Sat Nov 29 08:17:42 EST 2025
Tue Nov 18 21:41:56 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 148
Language English
License Copyright ©ERS 2018.
ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-6994affd72dc7ac946ef19b9f11043888295dd33d3d2a9561047cb5cef137f1c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-7000-5777
0000-0002-8551-3598
0000-0002-2597-574X
OpenAccessLink https://doaj.org/article/38dced6107154f478f53f8923c3ea0a7
PMID 29898905
PQID 2055613100
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_38dced6107154f478f53f8923c3ea0a7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9488456
proquest_miscellaneous_2055613100
pubmed_primary_29898905
crossref_citationtrail_10_1183_16000617_0035_2018
crossref_primary_10_1183_16000617_0035_2018
PublicationCentury 2000
PublicationDate 2018-06-30
PublicationDateYYYYMMDD 2018-06-30
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-30
  day: 30
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European respiratory review
PublicationTitleAlternate Eur Respir Rev
PublicationYear 2018
Publisher European Respiratory Society
Publisher_xml – name: European Respiratory Society
References 2024102403352954000_27.148.180035.40
2024102403352954000_27.148.180035.41
2024102403352954000_27.148.180035.44
2024102403352954000_27.148.180035.42
2024102403352954000_27.148.180035.43
Dara (2024102403352954000_27.148.180035.78) 2017; 21
Tiberi (2024102403352954000_27.148.180035.99) 2018; 24
2024102403352954000_27.148.180035.37
2024102403352954000_27.148.180035.38
2024102403352954000_27.148.180035.35
Holguin (2024102403352954000_27.148.180035.83) 2017; 14
2024102403352954000_27.148.180035.36
2024102403352954000_27.148.180035.39
2024102403352954000_27.148.180035.34
Duarte (2024102403352954000_27.148.180035.100) 2018; 24
2024102403352954000_27.148.180035.27
2024102403352954000_27.148.180035.24
2024102403352954000_27.148.180035.25
Duarte (2024102403352954000_27.148.180035.28) 2018; 44
2024102403352954000_27.148.180035.29
Styblo (2024102403352954000_27.148.180035.8) 1969; 42
Maryandyshev (2024102403352954000_27.148.180035.66) 2017; 23
D'Ambrosio (2024102403352954000_27.148.180035.98) 2018; 24
2024102403352954000_27.148.180035.22
2024102403352954000_27.148.180035.23
2024102403352954000_27.148.180035.20
2024102403352954000_27.148.180035.21
Carter (2024102403352954000_27.148.180035.30) 2018; 6
2024102403352954000_27.148.180035.15
2024102403352954000_27.148.180035.16
2024102403352954000_27.148.180035.13
2024102403352954000_27.148.180035.14
2024102403352954000_27.148.180035.19
Torres-Duque (2024102403352954000_27.148.180035.72) 2018; 54
2024102403352954000_27.148.180035.17
2024102403352954000_27.148.180035.18
2024102403352954000_27.148.180035.95
2024102403352954000_27.148.180035.96
2024102403352954000_27.148.180035.93
2024102403352954000_27.148.180035.94
2024102403352954000_27.148.180035.11
2024102403352954000_27.148.180035.12
2024102403352954000_27.148.180035.97
2024102403352954000_27.148.180035.10
Muñoz-Torrico (2024102403352954000_27.148.180035.87) 2017; 53
Javaid (2024102403352954000_27.148.180035.45) 2017; 49
Muñoz-Torrico (2024102403352954000_27.148.180035.86) 2017; 23
2024102403352954000_27.148.180035.91
2024102403352954000_27.148.180035.92
2024102403352954000_27.148.180035.90
García-Basteiro (2024102403352954000_27.148.180035.33) 2018; 24
2024102403352954000_27.148.180035.101
2024102403352954000_27.148.180035.102
2024102403352954000_27.148.180035.84
Migliori (2024102403352954000_27.148.180035.31) 2018; 6
2024102403352954000_27.148.180035.82
2024102403352954000_27.148.180035.88
2024102403352954000_27.148.180035.89
2024102403352954000_27.148.180035.80
2024102403352954000_27.148.180035.81
Nicolai (2024102403352954000_27.148.180035.85) 2015; 373
2024102403352954000_27.148.180035.9
2024102403352954000_27.148.180035.7
2024102403352954000_27.148.180035.6
2024102403352954000_27.148.180035.1
2024102403352954000_27.148.180035.79
2024102403352954000_27.148.180035.5
2024102403352954000_27.148.180035.4
2024102403352954000_27.148.180035.3
2024102403352954000_27.148.180035.2
2024102403352954000_27.148.180035.73
2024102403352954000_27.148.180035.74
2024102403352954000_27.148.180035.71
2024102403352954000_27.148.180035.77
2024102403352954000_27.148.180035.75
2024102403352954000_27.148.180035.76
Silva (2024102403352954000_27.148.180035.32) 2018; 134
2024102403352954000_27.148.180035.70
2024102403352954000_27.148.180035.68
2024102403352954000_27.148.180035.69
2024102403352954000_27.148.180035.62
2024102403352954000_27.148.180035.63
2024102403352954000_27.148.180035.60
2024102403352954000_27.148.180035.61
2024102403352954000_27.148.180035.67
2024102403352954000_27.148.180035.64
2024102403352954000_27.148.180035.65
Petersen (2024102403352954000_27.148.180035.26) 2017; 56
2024102403352954000_27.148.180035.59
2024102403352954000_27.148.180035.57
2024102403352954000_27.148.180035.58
2024102403352954000_27.148.180035.51
2024102403352954000_27.148.180035.52
2024102403352954000_27.148.180035.50
2024102403352954000_27.148.180035.55
2024102403352954000_27.148.180035.56
2024102403352954000_27.148.180035.53
2024102403352954000_27.148.180035.54
2024102403352954000_27.148.180035.48
2024102403352954000_27.148.180035.49
2024102403352954000_27.148.180035.46
2024102403352954000_27.148.180035.47
References_xml – ident: 2024102403352954000_27.148.180035.90
  doi: 10.1183/09031936.00079413
– ident: 2024102403352954000_27.148.180035.6
  doi: 10.1016/j.ijid.2016.11.416
– ident: 2024102403352954000_27.148.180035.101
– ident: 2024102403352954000_27.148.180035.91
  doi: 10.1183/09031936.00204611
– ident: 2024102403352954000_27.148.180035.60
  doi: 10.1183/13993003.00214-2016
– ident: 2024102403352954000_27.148.180035.71
  doi: 10.1183/13993003.01549-2016
– ident: 2024102403352954000_27.148.180035.38
– volume: 373
  start-page: 1593
  year: 2015
  ident: 2024102403352954000_27.148.180035.85
  article-title: Caring for the wave of refugees in Munich
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp1512139
– ident: 2024102403352954000_27.148.180035.42
  doi: 10.1183/13993003.01992-2016
– ident: 2024102403352954000_27.148.180035.5
  doi: 10.1056/NEJMc1212308
– ident: 2024102403352954000_27.148.180035.95
  doi: 10.1183/13993003.00956-2016
– ident: 2024102403352954000_27.148.180035.3
  doi: 10.1183/09031936.00134712
– ident: 2024102403352954000_27.148.180035.37
  doi: 10.1093/cid/civ609
– ident: 2024102403352954000_27.148.180035.58
  doi: 10.1183/13993003.00606-2015
– ident: 2024102403352954000_27.148.180035.21
  doi: 10.1183/13993003.01245-2015
– volume: 23
  start-page: 27
  year: 2017
  ident: 2024102403352954000_27.148.180035.86
  article-title: Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data
  publication-title: Rev Port Pneumol (2006)
– ident: 2024102403352954000_27.148.180035.27
  doi: 10.1183/09031936.02.00261402
– ident: 2024102403352954000_27.148.180035.62
  doi: 10.1183/13993003.01278-2015
– ident: 2024102403352954000_27.148.180035.10
– ident: 2024102403352954000_27.148.180035.4
  doi: 10.1016/S0140-6736(15)60570-0
– volume: 42
  start-page: 5
  year: 1969
  ident: 2024102403352954000_27.148.180035.8
  article-title: Tuberculosis Surveillance Research Unit Report No. 1: the transmission of tubercle bacilli; its trend in a human population
  publication-title: Bull Int Union Tuberc
– ident: 2024102403352954000_27.148.180035.54
  doi: 10.1183/09031936.00022912
– ident: 2024102403352954000_27.148.180035.2
  doi: 10.1183/09031936.00136312
– ident: 2024102403352954000_27.148.180035.82
  doi: 10.1586/eri.12.168
– ident: 2024102403352954000_27.148.180035.25
  doi: 10.1183/13993003.00274-2018
– ident: 2024102403352954000_27.148.180035.44
  doi: 10.1183/13993003.00463-2017
– ident: 2024102403352954000_27.148.180035.63
  doi: 10.1183/13993003.02445-2016
– ident: 2024102403352954000_27.148.180035.46
  doi: 10.1183/13993003.00223-2017
– ident: 2024102403352954000_27.148.180035.1
– ident: 2024102403352954000_27.148.180035.48
  doi: 10.1183/13993003.00753-2017
– ident: 2024102403352954000_27.148.180035.88
– volume: 6
  start-page: e475
  year: 2018
  ident: 2024102403352954000_27.148.180035.31
  article-title: Predicting the effect of improved socioeconomic health determinants on the tuberculosis epidemic
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(18)30189-X
– ident: 2024102403352954000_27.148.180035.9
  doi: 10.1183/09031936.00019410
– ident: 2024102403352954000_27.148.180035.69
  doi: 10.1183/13993003.00146-2017
– volume: 24
  start-page: 86
  year: 2018
  ident: 2024102403352954000_27.148.180035.99
  article-title: New drugs and perspectives for new anti-tuberculosis regimens
  publication-title: Pulmonology
  doi: 10.1016/j.rppnen.2017.10.009
– ident: 2024102403352954000_27.148.180035.74
– ident: 2024102403352954000_27.148.180035.17
  doi: 10.1183/09031936.00064314
– volume: 14
  start-page: 153
  year: 2017
  ident: 2024102403352954000_27.148.180035.83
  article-title: Respiratory health in migrant populations: a crisis overlooked
  publication-title: Ann Am Thorac Soc
  doi: 10.1513/AnnalsATS.201608-592PS
– ident: 2024102403352954000_27.148.180035.40
  doi: 10.1183/13993003.00061-2017
– volume: 53
  start-page: 245
  year: 2017
  ident: 2024102403352954000_27.148.180035.87
  article-title: Diabetes is associated with severe adverse events in multidrug-resistant tuberculosis
  publication-title: Arch Bronconeumol
  doi: 10.1016/j.arbres.2016.10.021
– volume: 134
  start-page: 12
  year: 2018
  ident: 2024102403352954000_27.148.180035.32
  article-title: Diagnostic performances of the Xpert MTB/RIF in Brazil
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2017.11.012
– volume: 6
  start-page: e514
  year: 2018
  ident: 2024102403352954000_27.148.180035.30
  article-title: The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(18)30195-5
– ident: 2024102403352954000_27.148.180035.77
  doi: 10.1183/13993003.00840-2016
– ident: 2024102403352954000_27.148.180035.75
  doi: 10.1183/13993003.02242-2016
– ident: 2024102403352954000_27.148.180035.29
  doi: 10.1146/annurev-publhealth-031912-114431
– ident: 2024102403352954000_27.148.180035.20
  doi: 10.1183/13993003.00098-2018
– ident: 2024102403352954000_27.148.180035.67
  doi: 10.1183/13993003.00637-2016
– ident: 2024102403352954000_27.148.180035.47
  doi: 10.1183/13993003.02309-2016
– ident: 2024102403352954000_27.148.180035.53
  doi: 10.1183/09031936.00116011
– ident: 2024102403352954000_27.148.180035.57
  doi: 10.1183/09031936.00135014
– ident: 2024102403352954000_27.148.180035.61
  doi: 10.1183/13993003.02146-2015
– volume: 23
  start-page: 1718
  year: 2017
  ident: 2024102403352954000_27.148.180035.66
  article-title: Bedaquiline and delamanid combination treatment of 5 patients with pulmonary extensively drug-resistant tuberculosis
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2310.170834
– ident: 2024102403352954000_27.148.180035.97
  doi: 10.1183/13993003.02027-2017
– ident: 2024102403352954000_27.148.180035.73
  doi: 10.1183/09031936.00198813
– ident: 2024102403352954000_27.148.180035.65
  doi: 10.1183/13993003.00705-2016
– ident: 2024102403352954000_27.148.180035.14
  doi: 10.1183/13993003.01459-2016
– ident: 2024102403352954000_27.148.180035.76
  doi: 10.1183/13993003.00377-2016
– ident: 2024102403352954000_27.148.180035.55
  doi: 10.1183/09031936.00191712
– ident: 2024102403352954000_27.148.180035.64
  doi: 10.1183/13993003.00387-2017
– ident: 2024102403352954000_27.148.180035.93
  doi: 10.1016/S0140-6736(15)00322-0
– ident: 2024102403352954000_27.148.180035.80
  doi: 10.1183/13993003.01324-2015
– volume: 24
  start-page: 132
  year: 2018
  ident: 2024102403352954000_27.148.180035.98
  article-title: Team approach to manage difficult-to-treat TB cases: experiences in Europe and beyond
  publication-title: Pulmonology
  doi: 10.1016/j.rppnen.2017.10.005
– ident: 2024102403352954000_27.148.180035.56
  doi: 10.1183/09031936.00145014
– ident: 2024102403352954000_27.148.180035.11
– ident: 2024102403352954000_27.148.180035.43
  doi: 10.1183/13993003.00228-2017
– ident: 2024102403352954000_27.148.180035.34
– ident: 2024102403352954000_27.148.180035.19
– ident: 2024102403352954000_27.148.180035.35
  doi: 10.1183/09031936.00157212
– ident: 2024102403352954000_27.148.180035.50
  doi: 10.1183/09031936.00009509
– ident: 2024102403352954000_27.148.180035.81
  doi: 10.1183/13993003.01597-2015
– ident: 2024102403352954000_27.148.180035.94
  doi: 10.1183/09031936.96.09051097
– ident: 2024102403352954000_27.148.180035.23
  doi: 10.1183/09031936.00084310
– ident: 2024102403352954000_27.148.180035.41
  doi: 10.1183/13993003.01249-2016
– volume: 56
  start-page: 34
  year: 2017
  ident: 2024102403352954000_27.148.180035.26
  article-title: De-isolation of patients with pulmonary tuberculosis after start of treatment – clear, unequivocal guidelines are missing
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2017.01.029
– ident: 2024102403352954000_27.148.180035.51
  doi: 10.1093/jac/dkp265
– volume: 24
  start-page: 73
  year: 2018
  ident: 2024102403352954000_27.148.180035.33
  article-title: Point of care diagnostics for tuberculosis
  publication-title: Pulmonology
  doi: 10.1016/j.rppnen.2017.12.002
– ident: 2024102403352954000_27.148.180035.96
  doi: 10.1183/09031936.00044314
– ident: 2024102403352954000_27.148.180035.68
  doi: 10.1183/13993003.01891-2015
– ident: 2024102403352954000_27.148.180035.52
  doi: 10.1183/09031936.00195210
– ident: 2024102403352954000_27.148.180035.70
  doi: 10.1183/13993003.01462-2017
– ident: 2024102403352954000_27.148.180035.22
– ident: 2024102403352954000_27.148.180035.13
  doi: 10.1183/13993003.02678-2017
– ident: 2024102403352954000_27.148.180035.79
  doi: 10.1183/09031936.00053012
– ident: 2024102403352954000_27.148.180035.84
– ident: 2024102403352954000_27.148.180035.12
  doi: 10.1183/09031936.00203811
– ident: 2024102403352954000_27.148.180035.7
  doi: 10.1183/09031936.00025910
– volume: 24
  start-page: 115
  year: 2018
  ident: 2024102403352954000_27.148.180035.100
  article-title: Tuberculosis, social determinants and co-morbidities (including HIV)
  publication-title: Pulmonology
  doi: 10.1016/j.rppnen.2017.11.003
– ident: 2024102403352954000_27.148.180035.39
  doi: 10.1183/13993003.02308-2016
– ident: 2024102403352954000_27.148.180035.59
  doi: 10.1183/13993003.02185-2015
– volume: 54
  start-page: 7
  year: 2018
  ident: 2024102403352954000_27.148.180035.72
  article-title: Roadmap for tuberculosis elimination in Latin America and the Caribbean
  publication-title: Arch Bronconeumol
  doi: 10.1016/j.arbres.2017.07.004
– ident: 2024102403352954000_27.148.180035.15
  doi: 10.1183/09031936.00216613
– ident: 2024102403352954000_27.148.180035.102
– ident: 2024102403352954000_27.148.180035.16
– ident: 2024102403352954000_27.148.180035.89
– ident: 2024102403352954000_27.148.180035.18
  doi: 10.1183/09031936.00214014
– ident: 2024102403352954000_27.148.180035.36
  doi: 10.1016/S1473-3099(16)00070-0
– volume: 21
  start-page: 727
  year: 2017
  ident: 2024102403352954000_27.148.180035.78
  article-title: Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.16.0940
– volume: 44
  start-page: 73
  year: 2018
  ident: 2024102403352954000_27.148.180035.28
  article-title: Eliminating tuberculosis in Latin America: making it the point
  publication-title: J Bras Pneumol
  doi: 10.1590/s1806-37562017000000449
– ident: 2024102403352954000_27.148.180035.24
  doi: 10.1183/09031936.00132114
– ident: 2024102403352954000_27.148.180035.92
– volume: 49
  start-page: 1601967
  year: 2017
  ident: 2024102403352954000_27.148.180035.45
  article-title: Applicability of World Health Organization's recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01967-2016
– ident: 2024102403352954000_27.148.180035.49
  doi: 10.1183/13993003.02267-2017
SSID ssj0040607
Score 2.4650784
SecondaryResourceType review_article
Snippet Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO)...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 180035
SubjectTerms Health and Politics
Title Tuberculosis elimination: where are we now?
URI https://www.ncbi.nlm.nih.gov/pubmed/29898905
https://www.proquest.com/docview/2055613100
https://pubmed.ncbi.nlm.nih.gov/PMC9488456
https://doaj.org/article/38dced6107154f478f53f8923c3ea0a7
Volume 27
WOSCitedRecordID wos000437470300019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1600-0617
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0040607
  issn: 0905-9180
  databaseCode: DOA
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB6SEEovIY8-Ni8c6C24sS3bknIJSciSQ7L0kJS9GVkj0YXFW_aR_fsZSfaSLaW95GAfbBnJ30iaGUbzDcA3hTWiqkVMN0MOCjdxLVHGSNMHMyFy5SOmPx_4YCCGQ_njTakvdyYs0AMH4C6YQG2QlDwnZW9zLmzBrCCzRDOjEuXzyMnq6ZypsAeTlgqJ0jJxlQhF0qXLCHaRlkFvf_dsjaT_xJpK8sz9fzM3_zw1-UYN9Xdhp7Ufo-sw7j3YMM0-fHhsI-QHcP60qM1UL8aT2WgWmbEv2uXAv4yWJB4TKbqWJmomy6tP8Ny_e7q9j9uCCLEuWD6PSylzZS3yDDVXWualsamspSUdnjPyZTNZIDKGBLNyGatJznVdaGrFuE01-wxbzaQxXyEqFeNY0gJMEHNr0pqlmcaUM6bQ1KroQdphUumWLdwVrRhX3msQrOpwdOyiReVw7MH56pvfgSvjn61vHNSrlo7n2j8g6Vet9Kv_Sb8HZ52gKloXLtihGjNZzKgLV_jThS968CUIbtVV5otmJvSTfE2ka2NZf9OMfnnubUkbHtmch-8x-CP46IAIpw-PYWs-XZgT2NYv89FsegqbfChO_bR-BV689nY
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tuberculosis+elimination%3A+where+are+we+now%3F&rft.jtitle=European+respiratory+review&rft.au=Alberto+Matteelli&rft.au=Adrian+Rendon&rft.au=Simon+Tiberi&rft.au=Seif+Al-Abri&rft.date=2018-06-30&rft.pub=European+Respiratory+Society&rft.issn=0905-9180&rft.eissn=1600-0617&rft.volume=27&rft.issue=148&rft_id=info:doi/10.1183%2F16000617.0035-2018&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_38dced6107154f478f53f8923c3ea0a7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-9180&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-9180&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-9180&client=summon